![]() ![]() |
Innate or natural or congenital or aspecific immune system

Acquired or adaptive or specific immune system
|
|
|
|
|
||||
|
|
|
|
|
|
|||
| CBA | AKR, C3H, B10.BR, C57BR | k | k | k | k | k | k |
| DBA/2 | BALB/c |
d | d | d | d | d | d |
| C57BL/10 (B10) | C57BL/6 |
b | b | b | b | b | b |
| A | A/He, A/Sn, A/Wy, B10A | a | k | k | k | d | d |
| A.SW | B10.S, SJL | s | s | s | s | s | s |
| A.TL | t1 | s | k | k | k | d | |
| DBA/1 | STOLI, B10.Q, BDP | q | q | q | q | q | q |
![]()

|
|
|
|
|
| B-cell lymphoma 38C13 | C3H/HeN | IgM/k | chimeric Ig: Id-g1/human k |
| chimeric Ig fused to GM-CSF | |||
| scFv fused to a IL-1b-derived peptide | |||
| scFv fused to MCP-3 chemokine | |||
| chimeric Ig (Id-g1/human k) in an Ad vector | |||
| splenic B-cell lymphoma A31 | CBA/Hx
C57B16F1 |
IgM/k | scFv fused to fragment C of tetanus toxin |
| scFv fused to Potexvirus capsid protein | |||
| 5T33M myeloma | C57BL/Kal
WRij |
IgG2b/k | scFv fused to fragment C of tetanus toxin |
| scFv fused to Potexvirus capsid protein | |||
| A20 B-cell lymphoma | Balb/c | IgG/k | scFv fused to MCP-3 chemokine |
| BCL1 B-cell lymphoma | Balb/c | IgM/l | chimeric Ig (Id-g1/human k) in an Ad vector |
| Daudi | CD19+ | ||
| K562 erythroleukemiaref1, ref2 | CD19– |

|
|
|
|
|